Literature DB >> 27208867

Analyzing the Impact of Palliative Care Interventions on Cost of Hospitalization: Practical Guidance for Choice of Dependent Variable.

Peter May1, Charles Normand2.   

Abstract

CONTEXT: Multiple cost analyses of hospital-based palliative care have been published in recent years, but there are important differences between studies in their choice of dependent variable, complicating interpretation of results.
OBJECTIVES: The purpose of this article was to compare three different established approaches to estimating treatment effect on hospital costs, to highlight that different approaches yield different results, and to provide some practical guidelines for investigators performing hospital cost analysis in future.
METHODS: A simple example is developed using simulated cost data for four hospitalized patients, one of whom receives usual care only and three of whom receive different interventions. The impacts of the interventions are calculated and compared for three different dependent variables: cost of hospitalization, mean daily costs, and "before-and-after" costs.
RESULTS: Both the magnitude of an intervention's cost-saving effect and the relative impact of different interventions vary according to which dependent variable is used. Cost of hospitalization provides the most useful results of the three options for evaluating an intervention's impact on resource use. Alternative approaches visible in the literature can be misleading with respect to cost effects. Where the intervention is first administered to different patients at different points in a hospital admission, incorporating intervention timing is essential to maximize accuracy of cost-effect estimates.
CONCLUSION: Investigators evaluating the impact of palliative care programs on hospital costs ought to use cost of hospitalization as the dependent variable in primary analysis unless the research question specifically justifies an alternative approach. Mean daily costs and "before-and-after" costs should be used only to address relevant research questions, and results must be interpreted carefully. Analyses should also incorporate timing of the intervention where appropriate.
Copyright © 2016 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Palliative care; cost analysis; economics; hospital

Mesh:

Year:  2016        PMID: 27208867     DOI: 10.1016/j.jpainsymman.2016.01.009

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  5 in total

1.  Economics of Palliative Care for Hospitalized Adults With Serious Illness: A Meta-analysis.

Authors:  Peter May; Charles Normand; J Brian Cassel; Egidio Del Fabbro; Robert L Fine; Reagan Menz; Corey A Morrison; Joan D Penrod; Chessie Robinson; R Sean Morrison
Journal:  JAMA Intern Med       Date:  2018-06-01       Impact factor: 21.873

Review 2.  Linking Quality and Spending to Measure Value for People with Serious Illness.

Authors:  Andrew M Ryan; Phillip E Rodgers
Journal:  J Palliat Med       Date:  2017-11-01       Impact factor: 2.947

3.  Improving palliative and end-of-life care with machine learning and routine data: a rapid review.

Authors:  Virginia Storick; Aoife O'Herlihy; Sarah Abdelhafeez; Rakesh Ahmed; Peter May
Journal:  HRB Open Res       Date:  2019-07-15

4.  Cost-saving prediction model of transfer to palliative care for terminal cancer patients in a Japanese general hospital.

Authors:  Yuki Hashimoto; Akitoshi Hayashi; Takashi Tonegawa; Lida Teng; Ataru Igarashi
Journal:  J Mark Access Health Policy       Date:  2022-03-27

5.  The association between palliative care team consultation and hospital costs for patients with advanced cancer: An observational study in 12 Dutch hospitals.

Authors:  Arianne Brinkman-Stoppelenburg; Suzanne Polinder; Branko F Olij; Barbara van den Berg; Nicolette Gunnink; Mathijs P Hendriks; Yvette M van der Linden; Daan Nieboer; Annemieke van der Padt-Pruijsten; Liesbeth A Peters; Brenda Roggeveen; Frederiek Terheggen; Sylvia Verhage; Maurice J van der Vorst; Ingrid Willemen; Yvonne Vergouwe; Agnes van der Heide
Journal:  Eur J Cancer Care (Engl)       Date:  2019-12-11       Impact factor: 2.520

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.